Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients

• Status: Completed
• Trial end date: 2014-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether the association of Thalidomide to Melphalan and Prednisone is effective in the treatment of newly diagnosed elderly multiple myeloma.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gruppo Italiano per lo Studio del Mieloma Multiplo
• Treatments: Melphalan; Prednisone; Thalidomide

Criteria

Inclusion Criteria:

• untreated myeloma patients

• age >65 years of age or younger but excluded from transplant procedure

• Durie & Salmon stage II or III myeloma and measurable disease.

• Patients agreed to use contraception

Exclusion Criteria:

• other cancer

• psychiatric disease and any grade 2 peripheral neuropathy